RAINBOWBSERainbow Children's Medicare LtdHighNeutral
Announced Wed, 27 May · 16:03 IST

Financial Results approved in the Board Meeting dated March 23, 2026.

Pat Growth 25pctExceptional ItemResults View source PDF

RAINBOW · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹1377.00
prior close
₹1377.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-1.0-1.0-0.0-1.8-3.1-1.3-1.5-2.3-4.1+6.3+1.8
Up moveDown movePending
AI summary

Rainbow Children's Medicare reported strong full-year results with standalone revenue of ₹15,456.6 million (up 6.3% YoY) and PAT of ₹2,500.2 million (up 5.2% YoY). On consolidated basis, revenue grew 12.4% to ₹17,030.8 million and PAT rose 15.3% to ₹2,815.4 million, boosted by the acquisition of Prashanthi Hospital (from July 2025) which contributed ₹191.5 million in revenue. The company recognized an exceptional item of ₹15.4 million due to provisioning for new labour codes. S.R. Batliboi & Associates issued an unmodified audit opinion. The Board recommended a dividend of ₹3.5 per share (35% payout) subject to shareholder approval at the July 2026 AGM.

Likely market impact

Solid FY26 results with healthy revenue and profit growth. The consolidation of recent acquisitions is driving above-standalone growth rates on a consolidated basis, which is positive for scale expansion.